Merit Medical(US:MMSI)2025-10-30 21:00Financial Performance (GAAP) - Revenue for Q3 2025 was $3842 million, a 130% increase compared to $3398 million in Q3 2024[8] - Year-to-date revenue in 2025 reached $11220 million, a 120% increase from $10014 million in the same period of 2024[8] - Net income for Q3 2025 was $278 million, a decrease of 24% compared to $284 million in Q3 2024[8] - Earnings per share for Q3 2025 were $046, a decrease of 30% compared to $048 in Q3 2024[8] Financial Performance (Non-GAAP) - Non-GAAP revenue for Q3 2025 was $3662 million, a 78% increase compared to $3398 million in Q3 2024[9] - Non-GAAP year-to-date revenue in 2025 reached $10697 million, a 68% increase from $10014 million in the same period of 2024[9] - Non-GAAP net income for Q3 2025 was $549 million, a 74% increase compared to $512 million in Q3 2024[9] - Non-GAAP earnings per share for Q3 2025 were $092, a 67% increase compared to $086 in Q3 2024[9] Revenue Breakdown by Region (Q3 2025) - US revenue was $230597 thousand, an 117% increase from $206492 thousand in Q3 2024[11] - EMEA revenue was $71531 thousand, a 223% increase from $58474 thousand in Q3 2024[11] Fiscal Year 2025 Financial Guidance - Net sales are projected to be between $1502 billion and $1515 billion, representing an 11%-12% year-over-year increase[14] - Non-GAAP earnings per share are expected to be between $366 and $379, representing a 6%-10% year-over-year increase[14]